nivolumab
bms
['nadim ii', 'nadim', 'nsclc', 'lung', 'lcsm,(-blcsm)', 'nivo', 'sclc', 'check,mate,816']
improved pcr observed in pts w/ resectable stage iiia nsclc treated w/ neoadjuvant nivo + chemo compared w/ chemo alone in nadim ii phase ii trial, strengthening the checkmate-816 findings. #asco22 #ascodailynews #lungcancer #lcsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.